Enterin and Parkinson’s UK to partner on dementia study
A new Phase II trial will study the drug ENT-01…
A new Phase II trial will study the drug ENT-01 for Parkinson’s Disease (PD)-associated dementia at sites in the UK and US.
List view / Grid view
A new Phase II trial will study the drug ENT-01…
A new Phase II trial will study the drug ENT-01 for Parkinson’s Disease (PD)-associated dementia at sites in the UK and US.
A pioneering clinical study will assess the safety, tolerability and…
A pioneering clinical study will assess the safety, tolerability and effectiveness of CBD in people with Parkinson's-related psychosis.